Related Experiment Video
Updated: Jul 4, 2026
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
A novel therapeutic paradigm to treat congenital hypothyroidism
Sarah Mathai1, Wayne S Cutfield, Alistair J Gunn
1Paediatric Endocrinology, Liggins Institute, University of Auckland and Starship Children's Health, Auckland, New Zealand.
Insights
This study shows a new treatment approach for congenital hypothyroidism (CH) using variable L-T4 doses based on cause and frequent monitoring. This method rapidly normalizes thyroid hormone levels in infants within two weeks.
Area of Science:
- Pediatric Endocrinology
- Neonatal Medicine
- Thyroid Disorders
Background:
- Congenital hypothyroidism (CH) requires timely thyroid hormone replacement therapy.
- Standard treatment protocols may not account for etiological variations in CH.
- Optimizing initial dosing and monitoring is crucial for infant outcomes.
Purpose of the Study:
- To evaluate a novel therapeutic strategy for CH.
- This strategy involves variable initial L-T4 doses tailored to CH etiology.
- The study aimed to assess effectiveness up to two years of age with frequent monitoring.
Main Methods:
- Retrospective cohort study of infants with primary CH diagnosed via newborn screening.
- L-T4 suspension initiated at etiological-specific doses (10, 12, 15 mcg/kg/day).
- Intensive monitoring of TSH and FT4 levels, with dose adjustments to maintain FT4 in the upper normal range.
Main Results:
- Seventy-eight percent of infants normalized FT4 within 7 days, 100% within 14 days.
- TSH normalized in 92% of infants by 21 days.
- Most infants achieved stable FT4 levels in the upper half of the normal range, with fewer dose adjustments needed in the second year.
Conclusions:
- Variable initial L-T4 dosing based on CH etiology is effective.
- This approach rapidly normalizes thyroid hormone levels.
- The strategy avoids persistent hyperthyroxinemia and ensures optimal thyroid hormone status in infants.
Objective:
To determine the effectiveness of a novel therapeutic paradigm to treat congenital hypothyroidism (CH) incorporating variable initial doses of L-T4 based on the underlying aetiology and frequent monitoring, up to 2 years of age.
Design:
Retrospective cohort study.
Patients:
Infants with primary CH diagnosed by newborn screening.
Measurements:
Treatment with L-T4 suspension initiated at 10, 12 and 15 microg/kg/day for dyshormonogenesis, ectopia and athyreosis, respectively. Serum TSH and free T4 (FT4) levels monitored weekly during the first 4 weeks, at 6 weeks, thereafter monthly during the first 2 years. Dose changes were made to keep FT4 level in upper half of the normal range.
Results:
Sixty-nine infants; 17 had dyshormonogenesis, 35 ectopia and 17 athyreosis. Seventy-eight percent of subjects normalized FT4 levels within 7 days of treatment and 100% within 14 days. TSH levels normalized in 26% of infants within 7 days and in 92% by 21 days. Supraphysiological levels of FT4 were noted in 28% of infants, for a maximum of 2 weeks. 48% infants needed one dose adjustment and 30% needed at least two in the first month. In 52 infants over the first 2 years, mean FT4 levels were consistently in the upper half of the normal range. Two or more dose adjustments every 3 months were made 57 times in the first year as compared to 19 times in the second year.
Conclusions:
A variable initial dose paradigm based on aetiology with frequent testing and using T4 suspension rapidly normalizes FT4 levels without producing persistent hyperthyroxinaemia.
Related Concept Videos
01:23Hypothyroidism II: Pathophysiology
01:20Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:27Hyperthyroidism II: Pathophysiology
01:25Hyperthyroidism I: Introduction
01:18Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
01:23The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...